Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sp1
|
ENSMUSG00000001280.6 | trans-acting transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_102421099_102421288 | Sp1 | 13605 | 0.089116 | -0.88 | 2.0e-02 | Click! |
chr15_102393605_102393940 | Sp1 | 12371 | 0.086825 | 0.87 | 2.4e-02 | Click! |
chr15_102405547_102406323 | Sp1 | 208 | 0.875723 | 0.76 | 8.0e-02 | Click! |
chr15_102399675_102399849 | Sp1 | 6381 | 0.098830 | 0.71 | 1.2e-01 | Click! |
chr15_102406581_102406754 | Sp1 | 88 | 0.938364 | 0.69 | 1.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_98766772_98767040 | 5.87 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
3520 |
0.12 |
chr11_98767399_98767584 | 5.02 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
2935 |
0.14 |
chr11_98767825_98767976 | 4.29 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
2526 |
0.15 |
chr9_106452941_106453115 | 3.81 |
Gm28959 |
predicted gene 28959 |
110 |
0.68 |
chr11_98767109_98767369 | 3.52 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
3187 |
0.13 |
chr3_90446574_90447024 | 3.24 |
Gm16048 |
predicted gene 16048 |
4784 |
0.1 |
chr3_89391856_89392032 | 3.11 |
Gm15417 |
predicted gene 15417 |
26 |
0.6 |
chr7_24500065_24500216 | 3.03 |
Cadm4 |
cell adhesion molecule 4 |
179 |
0.88 |
chr15_79690269_79690868 | 2.98 |
Gtpbp1 |
GTP binding protein 1 |
277 |
0.78 |
chr1_133908470_133908621 | 2.92 |
Optc |
opticin |
546 |
0.66 |
chr6_126048159_126048341 | 2.85 |
Ntf3 |
neurotrophin 3 |
116710 |
0.06 |
chr5_137741161_137741330 | 2.82 |
Nyap1 |
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 |
143 |
0.9 |
chr10_42950398_42950580 | 2.81 |
Scml4 |
Scm polycomb group protein like 4 |
10608 |
0.19 |
chr17_27557519_27557704 | 2.80 |
Hmga1 |
high mobility group AT-hook 1 |
916 |
0.28 |
chr2_44927013_44927284 | 2.77 |
Gtdc1 |
glycosyltransferase-like domain containing 1 |
1 |
0.99 |
chr12_25092894_25093391 | 2.71 |
Id2 |
inhibitor of DNA binding 2 |
2945 |
0.22 |
chr2_94273299_94273450 | 2.65 |
Mir670hg |
MIR670 host gene (non-protein coding) |
8456 |
0.15 |
chr3_90473370_90473521 | 2.58 |
Gm43595 |
predicted gene 43595 |
2486 |
0.12 |
chr7_17056077_17056249 | 2.57 |
Hif3a |
hypoxia inducible factor 3, alpha subunit |
516 |
0.64 |
chr15_7198920_7199078 | 2.57 |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
24070 |
0.22 |
chr2_73386657_73386837 | 2.47 |
Gpr155 |
G protein-coupled receptor 155 |
175 |
0.55 |
chr5_140830390_140830868 | 2.46 |
Gna12 |
guanine nucleotide binding protein, alpha 12 |
198 |
0.95 |
chrX_20425434_20425724 | 2.39 |
Jade3 |
jade family PHD finger 3 |
109 |
0.96 |
chr11_98770256_98770457 | 2.37 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
70 |
0.94 |
chr5_33694927_33695093 | 2.35 |
Gm42965 |
predicted gene 42965 |
12036 |
0.1 |
chr6_113306564_113306942 | 2.34 |
Gm43935 |
predicted gene, 43935 |
79 |
0.8 |
chr11_62076764_62076946 | 2.33 |
Specc1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
140 |
0.96 |
chr8_119445523_119446899 | 2.30 |
Necab2 |
N-terminal EF-hand calcium binding protein 2 |
508 |
0.74 |
chr9_122294480_122294638 | 2.30 |
Ano10 |
anoctamin 10 |
136 |
0.92 |
chr8_84984897_84985063 | 2.29 |
Hook2 |
hook microtubule tethering protein 2 |
5623 |
0.06 |
chr13_36736119_36736534 | 2.27 |
Nrn1 |
neuritin 1 |
1195 |
0.44 |
chr5_105700503_105701198 | 2.27 |
Lrrc8d |
leucine rich repeat containing 8D |
16 |
0.98 |
chr16_22163049_22163219 | 2.24 |
Igf2bp2 |
insulin-like growth factor 2 mRNA binding protein 2 |
115 |
0.96 |
chr11_3983568_3983719 | 2.24 |
Gal3st1 |
galactose-3-O-sulfotransferase 1 |
7 |
0.95 |
chr9_107667421_107667613 | 2.23 |
Slc38a3 |
solute carrier family 38, member 3 |
91 |
0.92 |
chr5_137349852_137350199 | 2.21 |
Ephb4 |
Eph receptor B4 |
84 |
0.93 |
chr2_34904821_34905227 | 2.20 |
Phf19 |
PHD finger protein 19 |
117 |
0.93 |
chr11_75462092_75462507 | 2.20 |
Tlcd2 |
TLC domain containing 2 |
584 |
0.35 |
chr7_145056434_145056606 | 2.18 |
Gm45181 |
predicted gene 45181 |
106476 |
0.05 |
chr11_89028954_89029121 | 2.17 |
Trim25 |
tripartite motif-containing 25 |
29661 |
0.09 |
chr9_8003649_8004083 | 2.17 |
Yap1 |
yes-associated protein 1 |
91 |
0.94 |
chr14_48475671_48475841 | 2.15 |
Tmem260 |
transmembrane protein 260 |
3434 |
0.2 |
chr12_108179483_108179687 | 2.14 |
Ccnk |
cyclin K |
6 |
0.8 |
chr5_109558445_109558806 | 2.14 |
Crlf2 |
cytokine receptor-like factor 2 |
311 |
0.86 |
chr1_164149200_164149369 | 2.11 |
Selp |
selectin, platelet |
2521 |
0.15 |
chr10_75835778_75835936 | 2.11 |
Gstt2 |
glutathione S-transferase, theta 2 |
976 |
0.36 |
chr18_21300208_21300569 | 2.10 |
Garem1 |
GRB2 associated regulator of MAPK1 subtype 1 |
250 |
0.91 |
chr6_97205515_97205853 | 2.10 |
Uba3 |
ubiquitin-like modifier activating enzyme 3 |
37 |
0.97 |
chr11_98773925_98774148 | 2.09 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
1297 |
0.27 |
chr12_72085579_72085776 | 2.07 |
Jkamp |
JNK1/MAPK8-associated membrane protein |
88 |
0.7 |
chr16_10993126_10993301 | 2.06 |
Litaf |
LPS-induced TN factor |
92 |
0.93 |
chr15_83366960_83367360 | 2.06 |
1700001L05Rik |
RIKEN cDNA 1700001L05 gene |
117 |
0.95 |
chr10_77606495_77606666 | 2.04 |
Sumo3 |
small ubiquitin-like modifier 3 |
9 |
0.84 |
chr8_119862106_119862265 | 2.04 |
Klhl36 |
kelch-like 36 |
81 |
0.97 |
chr10_5823911_5824075 | 2.03 |
Mtrf1l |
mitochondrial translational release factor 1-like |
83 |
0.98 |
chr7_35333860_35334195 | 2.03 |
Rhpn2 |
rhophilin, Rho GTPase binding protein 2 |
143 |
0.94 |
chr17_46160193_46160368 | 2.03 |
Gtpbp2 |
GTP binding protein 2 |
752 |
0.48 |
chr16_96082466_96082654 | 2.03 |
Brwd1 |
bromodomain and WD repeat domain containing 1 |
34 |
0.59 |
chr8_84908505_84908674 | 2.01 |
Dnase2a |
deoxyribonuclease II alpha |
29 |
0.93 |
chr6_145865476_145865643 | 2.01 |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
1 |
0.97 |
chr2_68873804_68874167 | 2.01 |
Cers6 |
ceramide synthase 6 |
12399 |
0.14 |
chr15_80159342_80159507 | 2.00 |
Mgat3 |
mannoside acetylglucosaminyltransferase 3 |
14297 |
0.11 |
chr14_20929184_20929360 | 1.99 |
Vcl |
vinculin |
126 |
0.97 |
chr4_129248394_129248565 | 1.99 |
C77080 |
expressed sequence C77080 |
36 |
0.96 |
chrX_13846465_13846885 | 1.98 |
Cask |
calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
60 |
0.98 |
chr8_94172420_94173095 | 1.97 |
Mt2 |
metallothionein 2 |
93 |
0.88 |
chr7_19933327_19933498 | 1.97 |
Igsf23 |
immunoglobulin superfamily, member 23 |
11486 |
0.07 |
chr9_104002362_104002733 | 1.97 |
Nphp3 |
nephronophthisis 3 (adolescent) |
1 |
0.73 |
chr2_120628935_120629093 | 1.96 |
Stard9 |
START domain containing 9 |
107 |
0.95 |
chr2_76648131_76648337 | 1.96 |
Prkra |
protein kinase, interferon inducible double stranded RNA dependent activator |
219 |
0.51 |
chr9_107675603_107675819 | 1.95 |
Gnat1 |
guanine nucleotide binding protein, alpha transducing 1 |
730 |
0.43 |
chr11_60115326_60115502 | 1.92 |
4930412M03Rik |
RIKEN cDNA 4930412M03 gene |
184 |
0.93 |
chr11_117875729_117875880 | 1.92 |
Tha1 |
threonine aldolase 1 |
2323 |
0.16 |
chr8_124663267_124663448 | 1.92 |
2310022B05Rik |
RIKEN cDNA 2310022B05 gene |
12 |
0.97 |
chr14_51913265_51913559 | 1.91 |
Ndrg2 |
N-myc downstream regulated gene 2 |
18 |
0.94 |
chr5_74647656_74647938 | 1.90 |
Lnx1 |
ligand of numb-protein X 1 |
24276 |
0.16 |
chr5_122158077_122158391 | 1.90 |
Ppp1cc |
protein phosphatase 1 catalytic subunit gamma |
44 |
0.96 |
chr17_74489716_74489885 | 1.88 |
Yipf4 |
Yip1 domain family, member 4 |
136 |
0.95 |
chr15_102014758_102014925 | 1.88 |
Krt8 |
keratin 8 |
10359 |
0.11 |
chr19_36409926_36410077 | 1.88 |
Pcgf5 |
polycomb group ring finger 5 |
253 |
0.9 |
chr10_42275538_42275830 | 1.86 |
Foxo3 |
forkhead box O3 |
1012 |
0.63 |
chr5_134941937_134942100 | 1.85 |
Mettl27 |
methyltransferase like 27 |
1556 |
0.18 |
chr1_88316276_88316427 | 1.85 |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
2562 |
0.2 |
chr2_34905239_34905414 | 1.85 |
Phf19 |
PHD finger protein 19 |
419 |
0.73 |
chr11_118729562_118729743 | 1.85 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
31389 |
0.18 |
chr6_3182898_3183288 | 1.84 |
Gm42642 |
predicted gene 42642 |
109 |
0.95 |
chr11_87748776_87748945 | 1.83 |
Mir142hg |
Mir142 host gene (non-protein coding) |
6717 |
0.09 |
chr11_86484356_86484600 | 1.82 |
Rnft1 |
ring finger protein, transmembrane 1 |
179 |
0.94 |
chr12_108792800_108792965 | 1.81 |
Yy1 |
YY1 transcription factor |
91 |
0.56 |
chr9_107676427_107676600 | 1.81 |
Gnat1 |
guanine nucleotide binding protein, alpha transducing 1 |
72 |
0.93 |
chrX_38564990_38565180 | 1.80 |
Cul4b |
cullin 4B |
423 |
0.84 |
chr13_101768239_101768390 | 1.79 |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
97 |
0.97 |
chr6_83456220_83456373 | 1.79 |
Tet3 |
tet methylcytosine dioxygenase 3 |
96 |
0.95 |
chr11_106193478_106193835 | 1.79 |
Strada |
STE20-related kinase adaptor alpha |
84 |
0.93 |
chr1_155112239_155112390 | 1.79 |
Ier5 |
immediate early response 5 |
12678 |
0.14 |
chr13_74121256_74121414 | 1.78 |
Slc9a3 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 |
122 |
0.96 |
chr4_124709066_124709229 | 1.78 |
Sf3a3 |
splicing factor 3a, subunit 3 |
5629 |
0.09 |
chr1_75317741_75318056 | 1.78 |
Dnpep |
aspartyl aminopeptidase |
92 |
0.94 |
chrX_73716457_73716639 | 1.78 |
Abcd1 |
ATP-binding cassette, sub-family D (ALD), member 1 |
49 |
0.83 |
chr10_39731356_39731646 | 1.77 |
E130307A14Rik |
RIKEN cDNA E130307A14 gene |
275 |
0.72 |
chr8_120589412_120589567 | 1.77 |
Gm10614 |
predicted gene 10614 |
42 |
0.68 |
chr2_132048483_132048634 | 1.77 |
Slc23a2 |
solute carrier family 23 (nucleobase transporters), member 2 |
8127 |
0.18 |
chr4_151044647_151045045 | 1.76 |
Per3 |
period circadian clock 3 |
181 |
0.94 |
chrX_36645402_36645564 | 1.76 |
Akap17b |
A kinase (PRKA) anchor protein 17B |
88 |
0.97 |
chr10_69910495_69910908 | 1.76 |
Ank3 |
ankyrin 3, epithelial |
4164 |
0.35 |
chr17_34120395_34120586 | 1.76 |
Gm50336 |
predicted gene, 50336 |
78 |
0.47 |
chr15_83704064_83704215 | 1.75 |
Scube1 |
signal peptide, CUB domain, EGF-like 1 |
20787 |
0.2 |
chr19_58441609_58442090 | 1.75 |
Gfra1 |
glial cell line derived neurotrophic factor family receptor alpha 1 |
12617 |
0.22 |
chr2_121866807_121866994 | 1.73 |
Casc4 |
cancer susceptibility candidate 4 |
70 |
0.66 |
chr15_97831496_97831660 | 1.73 |
Hdac7 |
histone deacetylase 7 |
84 |
0.97 |
chr1_125560441_125560619 | 1.73 |
Slc35f5 |
solute carrier family 35, member F5 |
65 |
0.98 |
chr14_18239148_18239309 | 1.73 |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
101 |
0.95 |
chr7_45053316_45053568 | 1.73 |
Prr12 |
proline rich 12 |
561 |
0.42 |
chr17_29490659_29490810 | 1.72 |
Pim1 |
proviral integration site 1 |
19 |
0.88 |
chr11_50188709_50189126 | 1.72 |
Mrnip |
MRN complex interacting protein |
14010 |
0.1 |
chr1_72824439_72824598 | 1.72 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
15 |
0.98 |
chr16_43979812_43979963 | 1.72 |
Zdhhc23 |
zinc finger, DHHC domain containing 23 |
96 |
0.96 |
chr10_80590320_80590675 | 1.72 |
Abhd17a |
abhydrolase domain containing 17A |
156 |
0.81 |
chr17_35164874_35165221 | 1.71 |
Gm17705 |
predicted gene, 17705 |
72 |
0.57 |
chr6_56714728_56714895 | 1.70 |
Avl9 |
AVL9 cell migration associated |
88 |
0.97 |
chr12_110418068_110418274 | 1.70 |
Ppp2r5c |
protein phosphatase 2, regulatory subunit B', gamma |
28949 |
0.14 |
chr6_72899633_72900030 | 1.70 |
Kcmf1 |
potassium channel modulatory factor 1 |
128 |
0.95 |
chr9_110654093_110654253 | 1.70 |
Nbeal2 |
neurobeachin-like 2 |
12 |
0.94 |
chr14_25456911_25457241 | 1.70 |
Zmiz1os1 |
Zmiz1 opposite strand 1 |
722 |
0.52 |
chr3_97227497_97227689 | 1.70 |
Bcl9 |
B cell CLL/lymphoma 9 |
58 |
0.97 |
chr5_139150009_139150167 | 1.69 |
Prkar1b |
protein kinase, cAMP dependent regulatory, type I beta |
87 |
0.54 |
chr10_81232992_81233159 | 1.69 |
Zfr2 |
zinc finger RNA binding protein 2 |
80 |
0.91 |
chr5_123135557_123135724 | 1.68 |
Gm38102 |
predicted gene, 38102 |
121 |
0.9 |
chr10_127668046_127668306 | 1.67 |
Nab2 |
Ngfi-A binding protein 2 |
392 |
0.62 |
chr11_97404359_97404555 | 1.67 |
Arhgap23 |
Rho GTPase activating protein 23 |
11076 |
0.15 |
chr4_136090324_136090475 | 1.67 |
Gm13009 |
predicted gene 13009 |
15427 |
0.12 |
chr9_47530018_47530357 | 1.66 |
Cadm1 |
cell adhesion molecule 1 |
14 |
0.98 |
chr10_118722203_118722619 | 1.66 |
Gm47425 |
predicted gene, 47425 |
2983 |
0.25 |
chr6_125165542_125165892 | 1.66 |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
56 |
0.92 |
chr11_114675343_114675509 | 1.66 |
Ttyh2 |
tweety family member 2 |
5 |
0.97 |
chr9_66802090_66802293 | 1.66 |
BC050972 |
cDNA sequence BC050972 |
368 |
0.78 |
chr5_139803654_139803817 | 1.66 |
Tmem184a |
transmembrane protein 184a |
4245 |
0.14 |
chr12_113098537_113098688 | 1.66 |
Mta1 |
metastasis associated 1 |
211 |
0.89 |
chr7_44590833_44590984 | 1.65 |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
22 |
0.77 |
chr4_45012182_45012362 | 1.64 |
Zbtb5 |
zinc finger and BTB domain containing 5 |
122 |
0.85 |
chr1_13103635_13103786 | 1.64 |
Prdm14 |
PR domain containing 14 |
23453 |
0.13 |
chr19_3388720_3388900 | 1.64 |
Tesmin |
testis expressed metallothionein like |
47 |
0.97 |
chr5_137398768_137398919 | 1.63 |
Zan |
zonadhesin |
2895 |
0.15 |
chr2_3283911_3284308 | 1.63 |
Nmt2 |
N-myristoyltransferase 2 |
103 |
0.96 |
chr10_81320539_81320949 | 1.63 |
Cactin |
cactin, spliceosome C complex subunit |
359 |
0.64 |
chr8_85083147_85083305 | 1.63 |
Man2b1 |
mannosidase 2, alpha B1 |
44 |
0.9 |
chr1_132520862_132521022 | 1.63 |
Cntn2 |
contactin 2 |
1785 |
0.28 |
chr11_93886528_93886679 | 1.63 |
Mbtd1 |
mbt domain containing 1 |
277 |
0.81 |
chr8_70839470_70839839 | 1.63 |
Arrdc2 |
arrestin domain containing 2 |
6 |
0.94 |
chr4_40854042_40854209 | 1.63 |
B4galt1 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
120 |
0.93 |
chr17_24736479_24736636 | 1.63 |
Msrb1 |
methionine sulfoxide reductase B1 |
85 |
0.9 |
chr14_25769128_25769300 | 1.62 |
Zcchc24 |
zinc finger, CCHC domain containing 24 |
175 |
0.94 |
chr11_55440384_55440535 | 1.61 |
Sparc |
secreted acidic cysteine rich glycoprotein |
17276 |
0.11 |
chr8_120589206_120589400 | 1.61 |
Gins2 |
GINS complex subunit 2 (Psf2 homolog) |
1 |
0.74 |
chr2_131491546_131492023 | 1.61 |
Smox |
spermine oxidase |
20 |
0.98 |
chr5_53196740_53196918 | 1.60 |
Sel1l3 |
sel-1 suppressor of lin-12-like 3 (C. elegans) |
16486 |
0.19 |
chrX_13071225_13071531 | 1.60 |
Usp9x |
ubiquitin specific peptidase 9, X chromosome |
120 |
0.97 |
chr10_80017491_80017661 | 1.60 |
Arhgap45 |
Rho GTPase activating protein 45 |
660 |
0.46 |
chr15_76659740_76659910 | 1.60 |
Kifc2 |
kinesin family member C2 |
33 |
0.52 |
chr2_6212986_6213147 | 1.60 |
Echdc3 |
enoyl Coenzyme A hydratase domain containing 3 |
33 |
0.97 |
chr11_98795069_98795435 | 1.60 |
Msl1 |
male specific lethal 1 |
264 |
0.84 |
chr8_33902816_33903036 | 1.59 |
Rbpms |
RNA binding protein gene with multiple splicing |
11162 |
0.17 |
chr3_104220440_104221564 | 1.59 |
Magi3 |
membrane associated guanylate kinase, WW and PDZ domain containing 3 |
628 |
0.6 |
chr1_20951472_20951648 | 1.59 |
Efhc1 |
EF-hand domain (C-terminal) containing 1 |
66 |
0.96 |
chr19_10191409_10191606 | 1.59 |
Mir6993 |
microRNA 6993 |
132 |
0.9 |
chr7_57590998_57591185 | 1.58 |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
71 |
0.98 |
chr11_97884121_97884287 | 1.58 |
Fbxo47 |
F-box protein 47 |
50 |
0.84 |
chr15_99875325_99875664 | 1.58 |
Lima1 |
LIM domain and actin binding 1 |
38 |
0.49 |
chr19_16132652_16132926 | 1.58 |
Gnaq |
guanine nucleotide binding protein, alpha q polypeptide |
42 |
0.98 |
chr13_41253417_41253699 | 1.57 |
Smim13 |
small integral membrane protein 13 |
3714 |
0.15 |
chr1_191718324_191718483 | 1.57 |
Lpgat1 |
lysophosphatidylglycerol acyltransferase 1 |
14 |
0.98 |
chr7_46838260_46838416 | 1.56 |
Ldha |
lactate dehydrogenase A |
3137 |
0.12 |
chr2_144178364_144178517 | 1.56 |
Gm5535 |
predicted gene 5535 |
646 |
0.67 |
chr11_115823836_115824112 | 1.55 |
Llgl2 |
LLGL2 scribble cell polarity complex component |
75 |
0.94 |
chr5_24685912_24686073 | 1.55 |
Nub1 |
negative regulator of ubiquitin-like proteins 1 |
5 |
0.96 |
chr11_52283256_52283951 | 1.55 |
Tcf7 |
transcription factor 7, T cell specific |
272 |
0.88 |
chr12_59011862_59012061 | 1.55 |
Sec23a |
SEC23 homolog A, COPII coat complex component |
56 |
0.95 |
chr17_30575942_30576108 | 1.55 |
Btbd9 |
BTB (POZ) domain containing 9 |
144 |
0.66 |
chr15_77150122_77150279 | 1.55 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
3356 |
0.18 |
chr2_25365586_25365760 | 1.54 |
Uap1l1 |
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 |
9 |
0.93 |
chr5_22344788_22344947 | 1.54 |
Reln |
reelin |
165 |
0.94 |
chr7_45923585_45923793 | 1.54 |
Ccdc114 |
coiled-coil domain containing 114 |
383 |
0.47 |
chr9_40773794_40774087 | 1.54 |
Clmp |
CXADR-like membrane protein |
154 |
0.91 |
chr2_154436165_154436337 | 1.54 |
Cbfa2t2 |
CBFA2/RUNX1 translocation partner 2 |
230 |
0.92 |
chr7_5014267_5014429 | 1.54 |
Zfp524 |
zinc finger protein 524 |
67 |
0.49 |
chr11_97685759_97685946 | 1.53 |
Cisd3 |
CDGSH iron sulfur domain 3 |
9 |
0.94 |
chr16_30257794_30257955 | 1.53 |
Gm49645 |
predicted gene, 49645 |
2722 |
0.2 |
chr14_65833964_65834127 | 1.53 |
Esco2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
51 |
0.97 |
chr7_127260691_127261039 | 1.53 |
Dctpp1 |
dCTP pyrophosphatase 1 |
156 |
0.87 |
chr1_75317292_75317486 | 1.53 |
Dnpep |
aspartyl aminopeptidase |
7 |
0.95 |
chr2_30807733_30807916 | 1.52 |
Ntmt1 |
N-terminal Xaa-Pro-Lys N-methyltransferase 1 |
2 |
0.96 |
chr18_35830200_35830390 | 1.52 |
Cxxc5 |
CXXC finger 5 |
19 |
0.93 |
chr7_132610799_132611117 | 1.52 |
Lhpp |
phospholysine phosphohistidine inorganic pyrophosphate phosphatase |
250 |
0.9 |
chr5_45534505_45534782 | 1.52 |
Fam184b |
family with sequence similarity 184, member B |
1899 |
0.22 |
chr9_113931000_113931188 | 1.51 |
Ubp1 |
upstream binding protein 1 |
160 |
0.96 |
chr11_98150432_98150615 | 1.51 |
Fbxl20 |
F-box and leucine-rich repeat protein 20 |
120 |
0.94 |
chr11_101839594_101839755 | 1.51 |
Gm11551 |
predicted gene 11551 |
46563 |
0.09 |
chr10_80115460_80115699 | 1.51 |
Stk11 |
serine/threonine kinase 11 |
224 |
0.85 |
chr15_25945393_25945754 | 1.50 |
Mir7212 |
microRNA 7212 |
2654 |
0.25 |
chr16_4586554_4586882 | 1.50 |
Glis2 |
GLIS family zinc finger 2 |
7995 |
0.13 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 8.6 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
1.1 | 3.3 | GO:0006868 | glutamine transport(GO:0006868) |
1.0 | 1.0 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) |
1.0 | 3.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.0 | 3.1 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.9 | 2.8 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.9 | 2.8 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.9 | 4.5 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.9 | 3.6 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.9 | 3.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.9 | 2.6 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.8 | 4.2 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.8 | 2.5 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.8 | 2.5 | GO:0008050 | female courtship behavior(GO:0008050) |
0.8 | 1.7 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
0.8 | 4.2 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.8 | 3.3 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.8 | 3.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.8 | 2.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.8 | 2.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.8 | 3.8 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.7 | 5.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.7 | 3.7 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.7 | 1.5 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.7 | 2.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.7 | 4.4 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.7 | 8.7 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.7 | 0.7 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.7 | 1.4 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.7 | 0.7 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.7 | 4.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.7 | 2.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.7 | 2.8 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.7 | 2.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.7 | 2.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.7 | 2.7 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.7 | 2.0 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.7 | 2.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.7 | 2.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 2.0 | GO:0097503 | sialylation(GO:0097503) |
0.7 | 1.3 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.7 | 2.7 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
0.7 | 2.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.6 | 1.9 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.6 | 1.3 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.6 | 3.9 | GO:0001705 | ectoderm formation(GO:0001705) |
0.6 | 2.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.6 | 1.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.6 | 1.9 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.6 | 1.9 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.6 | 1.9 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.6 | 1.9 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.6 | 5.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.6 | 1.9 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.6 | 5.6 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) |
0.6 | 1.2 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.6 | 4.2 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.6 | 0.6 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.6 | 2.9 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.6 | 1.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.6 | 2.8 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.6 | 1.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.6 | 0.6 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.6 | 1.7 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.5 | 1.6 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.5 | 1.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.5 | 2.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.5 | 1.6 | GO:0040031 | snRNA modification(GO:0040031) |
0.5 | 1.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.5 | 1.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.5 | 0.5 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.5 | 1.6 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.5 | 0.5 | GO:0060435 | bronchiole development(GO:0060435) |
0.5 | 4.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.5 | 1.1 | GO:0048382 | mesendoderm development(GO:0048382) |
0.5 | 1.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.5 | 5.8 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.5 | 1.6 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.5 | 2.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.5 | 1.6 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.5 | 2.6 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.5 | 1.6 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.5 | 1.0 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.5 | 1.0 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.5 | 1.5 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.5 | 2.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.5 | 1.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 3.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.5 | 1.0 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.5 | 1.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.5 | 1.5 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.5 | 2.0 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.5 | 3.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 2.5 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.5 | 1.5 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.5 | 1.0 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.5 | 0.5 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.5 | 3.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.5 | 1.9 | GO:0006848 | pyruvate transport(GO:0006848) |
0.5 | 4.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.5 | 0.5 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.5 | 1.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.5 | 1.9 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.5 | 1.0 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.5 | 1.9 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.5 | 2.4 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.5 | 1.4 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.5 | 1.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 1.9 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.5 | 1.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.5 | 2.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.5 | 1.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.5 | 2.8 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.5 | 1.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.5 | 1.8 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.5 | 1.8 | GO:0009414 | response to water deprivation(GO:0009414) |
0.5 | 1.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.5 | 1.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.5 | 7.7 | GO:0001893 | maternal placenta development(GO:0001893) |
0.5 | 0.9 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.4 | 1.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 1.3 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.4 | 2.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.4 | 1.3 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.4 | 0.9 | GO:0051182 | coenzyme transport(GO:0051182) |
0.4 | 2.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.4 | 2.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.4 | 0.9 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.4 | 2.2 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.4 | 0.4 | GO:0018377 | protein myristoylation(GO:0018377) |
0.4 | 3.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.4 | 1.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.4 | 3.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.4 | 1.3 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 1.3 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.4 | 1.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.4 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 1.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.4 | 0.9 | GO:0035425 | autocrine signaling(GO:0035425) |
0.4 | 1.3 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.4 | 0.4 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.4 | 0.9 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.4 | 4.2 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.4 | 0.8 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.4 | 2.9 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.4 | 2.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.4 | 0.4 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.4 | 2.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.4 | 3.8 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.4 | 1.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.4 | 2.1 | GO:0015879 | carnitine transport(GO:0015879) |
0.4 | 0.4 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.4 | 1.2 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.4 | 0.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.4 | 0.8 | GO:0072553 | terminal button organization(GO:0072553) |
0.4 | 0.4 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.4 | 1.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 1.6 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.4 | 1.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.4 | 2.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 3.3 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.4 | 2.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.4 | 0.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.4 | 0.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.4 | 0.8 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.4 | 2.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.4 | 0.4 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.4 | 1.6 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.4 | 2.4 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 1.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.4 | 2.0 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.4 | 0.8 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.4 | 1.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.4 | 1.6 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.4 | 1.6 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.4 | 1.6 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 1.2 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.4 | 0.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.4 | 1.2 | GO:2000562 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.4 | 1.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.4 | 2.3 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.4 | 4.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.4 | 1.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.4 | 2.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.4 | 1.5 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.4 | 0.8 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.4 | 0.4 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.4 | 1.9 | GO:0080009 | mRNA methylation(GO:0080009) |
0.4 | 0.8 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.4 | 0.8 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.4 | 1.1 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.4 | 1.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.4 | 1.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 1.1 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.4 | 4.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.4 | 3.4 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.4 | 1.9 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.4 | 0.4 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
0.4 | 2.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 2.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 0.4 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.4 | 1.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.4 | 1.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.4 | 0.7 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.4 | 1.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.4 | 1.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.4 | 1.8 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.4 | 0.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 1.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.4 | 0.4 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.4 | 1.8 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.4 | 1.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.4 | 2.9 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.4 | 1.8 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 1.4 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.4 | 1.1 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.4 | 1.8 | GO:0006983 | ER overload response(GO:0006983) |
0.4 | 2.9 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.4 | 2.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.4 | 0.4 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.4 | 5.0 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.4 | 3.2 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.4 | 1.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.4 | 1.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.4 | 0.7 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.4 | 1.1 | GO:0032264 | IMP salvage(GO:0032264) |
0.4 | 2.5 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.4 | 0.4 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.4 | 1.8 | GO:0002934 | desmosome organization(GO:0002934) |
0.4 | 0.7 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.4 | 0.4 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.3 | 1.4 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 0.7 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.3 | 0.3 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.3 | 1.0 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.3 | 1.4 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.3 | 0.7 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 1.4 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.3 | 4.4 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.3 | 1.0 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.3 | 1.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.3 | 1.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 0.3 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.3 | 2.7 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.3 | 1.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.3 | 4.0 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.3 | 1.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.3 | 1.3 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.3 | 0.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.3 | 2.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 0.7 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.3 | 1.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.3 | 0.7 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.3 | 1.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 0.7 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.3 | 1.0 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.3 | 1.0 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 0.7 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.3 | 3.9 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.3 | 1.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 1.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 1.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 1.3 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 1.0 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.3 | 1.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 1.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 0.3 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.3 | 2.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.3 | 1.3 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.3 | 3.5 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.3 | 1.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 1.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.3 | 1.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.3 | 1.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.3 | 0.3 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.3 | 1.9 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.3 | 0.6 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.3 | 1.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 1.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 1.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 0.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 0.3 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.3 | 4.4 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.3 | 0.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.3 | 0.6 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.3 | 1.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 1.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.3 | 0.6 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.3 | 3.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.3 | 1.5 | GO:1901631 | positive regulation of presynaptic membrane organization(GO:1901631) |
0.3 | 0.9 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 0.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.3 | 4.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 0.3 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.3 | 1.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 0.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.3 | 1.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.3 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.9 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.3 | 1.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 0.6 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.3 | 1.8 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.3 | 2.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.3 | 0.9 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 6.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.3 | 3.9 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 0.6 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.3 | 3.0 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 2.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.3 | 0.6 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.3 | 0.3 | GO:2000468 | neutrophil aggregation(GO:0070488) regulation of peroxidase activity(GO:2000468) |
0.3 | 1.2 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 1.8 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.3 | 0.9 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 0.9 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.3 | 0.9 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.3 | 0.9 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 1.7 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.3 | 2.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.3 | 0.9 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 0.9 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.3 | 0.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.3 | 0.6 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 0.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 0.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 0.9 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.3 | 0.3 | GO:0070989 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) oxidative demethylation(GO:0070989) |
0.3 | 0.6 | GO:0060268 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
0.3 | 1.1 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 1.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 0.9 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.3 | 0.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 1.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.3 | 0.6 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.3 | 0.3 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.3 | 0.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.3 | 1.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 1.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 0.8 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 1.9 | GO:0033572 | transferrin transport(GO:0033572) |
0.3 | 0.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.3 | 1.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 1.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 1.7 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.3 | 3.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 0.8 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.3 | 0.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 2.5 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.3 | 3.3 | GO:0070633 | transepithelial transport(GO:0070633) |
0.3 | 0.8 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.3 | 2.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.3 | 0.5 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.3 | 1.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.3 | 0.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.3 | 1.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 1.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.3 | 0.5 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.3 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.3 | 1.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.3 | 1.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.3 | 2.4 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.3 | 1.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 0.5 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 1.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 0.5 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.3 | 0.5 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.3 | 0.5 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.3 | 0.5 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.3 | 0.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 0.8 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.3 | 1.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 0.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 1.0 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.3 | 2.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.3 | 3.1 | GO:0042407 | cristae formation(GO:0042407) |
0.3 | 1.5 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.3 | 5.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 0.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 1.8 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 0.3 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.3 | 0.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 1.0 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.3 | 0.8 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.3 | 0.3 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.3 | 0.8 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 1.3 | GO:1904707 | regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
0.3 | 1.0 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.3 | 0.5 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.3 | 2.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.3 | 0.8 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.2 | 0.7 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 0.7 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 2.2 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.2 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 1.7 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.2 | 0.7 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 3.2 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.2 | 1.7 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.2 | 3.0 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.2 | 0.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 0.5 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 0.2 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.2 | 0.5 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.2 | 1.7 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 1.0 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.2 | 0.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 1.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.7 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.2 | 1.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.2 | 0.2 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.2 | 1.0 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 2.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.5 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.2 | 1.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.5 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.2 | 0.5 | GO:0070723 | response to cholesterol(GO:0070723) |
0.2 | 1.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 1.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 1.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 1.0 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.2 | 0.5 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.2 | 0.2 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.2 | 0.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.2 | 0.5 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.2 | 1.7 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 0.2 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.2 | 1.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.7 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.2 | 0.5 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 2.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 0.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 1.9 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.2 | 0.9 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.2 | 0.9 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 0.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.2 | 1.6 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 0.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.5 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.2 | 0.7 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 1.4 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.2 | 1.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 1.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 1.6 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.2 | 0.7 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 0.2 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.2 | 0.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 0.2 | GO:0006403 | RNA localization(GO:0006403) |
0.2 | 0.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 0.2 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 1.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 0.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.5 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.2 | 0.9 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.2 | 0.7 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.2 | 2.3 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.2 | 1.8 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 0.2 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 0.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 1.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.2 | 0.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.2 | 0.2 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.2 | 0.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 3.4 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.2 | 0.7 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 1.3 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.2 | 2.0 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.7 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.2 | 0.2 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.2 | 0.9 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.2 | 0.9 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 2.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 2.0 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.2 | 1.8 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.2 | 1.1 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.2 | 0.7 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.2 | 0.7 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.2 | 1.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 1.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 1.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.9 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.2 | 2.4 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.2 | 0.4 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.2 | 1.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 1.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 1.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.6 | GO:0006189 | IMP biosynthetic process(GO:0006188) 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.6 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.2 | 1.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 1.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 0.6 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.2 | 1.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 1.0 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.2 | 0.8 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 0.4 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.8 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 0.6 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.2 | 0.6 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 0.4 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.2 | 0.4 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.2 | 0.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.8 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 7.8 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.6 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.2 | 0.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 0.6 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 0.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 2.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 1.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.6 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.2 | 0.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.2 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.2 | 4.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.2 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.2 | 4.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 1.0 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 0.8 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 0.2 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.2 | 1.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.2 | 2.2 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 2.2 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.2 | 1.0 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 0.6 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.2 | 0.6 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 1.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.4 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 0.6 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.2 | 0.8 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 0.6 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 3.1 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.2 | 0.6 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 2.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.2 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 0.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 1.9 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 2.7 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.2 | 1.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 1.1 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 0.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.2 | 0.6 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.2 | GO:0071870 | cellular response to catecholamine stimulus(GO:0071870) |
0.2 | 3.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.2 | 0.8 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.2 | 1.9 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.2 | 8.3 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.2 | 0.8 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 0.8 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 0.8 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.2 | 0.6 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.2 | 0.2 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.2 | 3.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 1.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 1.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 6.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 0.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 1.3 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.4 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.2 | 0.2 | GO:0045073 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) |
0.2 | 0.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.2 | 1.8 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.2 | 0.5 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 0.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 0.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 2.4 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 2.2 | GO:0046931 | pore complex assembly(GO:0046931) |
0.2 | 0.2 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.2 | 0.5 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 0.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.2 | 0.2 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 0.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.2 | 0.4 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.2 | 0.2 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.2 | 0.5 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 1.6 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 2.0 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.2 | 1.8 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.2 | 0.4 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 0.2 | GO:1903573 | negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
0.2 | 1.6 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.2 | 2.3 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.2 | 0.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 1.9 | GO:0071548 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.2 | 0.7 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 4.9 | GO:0036503 | ERAD pathway(GO:0036503) |
0.2 | 0.3 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.2 | 0.2 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.2 | 0.3 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.2 | 0.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 0.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 0.5 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.2 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.2 | 0.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.2 | 0.5 | GO:0072262 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.2 | 0.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 1.0 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.2 | 0.3 | GO:0035794 | positive regulation of mitochondrial membrane permeability(GO:0035794) |
0.2 | 0.5 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.9 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.2 | 0.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 1.2 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.2 | 0.7 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.7 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 0.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.2 | 1.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 1.9 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.2 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.2 | 0.8 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.2 | 0.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 1.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 0.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 2.2 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.2 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 0.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 0.5 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 1.0 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.2 | 0.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.7 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 1.1 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.2 | 0.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 0.6 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 0.5 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 0.6 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.2 | 1.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 0.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 0.8 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.2 | 0.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.2 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.2 | 0.3 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 1.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.2 | 0.5 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.2 | 1.9 | GO:1902591 | single-organism membrane budding(GO:1902591) |
0.2 | 0.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 0.5 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 1.1 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 0.9 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.2 | 0.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 1.6 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.2 | 1.6 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.2 | 0.6 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.2 | 1.5 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 0.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.2 | 1.1 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.2 | 0.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.5 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 0.2 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.2 | 0.2 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 1.1 | GO:0046006 | regulation of activated T cell proliferation(GO:0046006) |
0.2 | 0.3 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.2 | 0.5 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.2 | 0.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 1.5 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 0.6 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 0.6 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 2.9 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.3 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.6 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.1 | 0.1 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 0.3 | GO:0071709 | membrane assembly(GO:0071709) |
0.1 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.6 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.6 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.3 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.1 | 0.9 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.6 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 4.1 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.7 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.1 | 0.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.4 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.1 | 0.4 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 1.5 | GO:0097484 | dendrite extension(GO:0097484) |
0.1 | 2.0 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 1.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.9 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.9 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.6 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.6 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 1.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.7 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.1 | 0.3 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 1.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 1.4 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.6 | GO:1990748 | cellular detoxification(GO:1990748) |
0.1 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 1.0 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.7 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 0.1 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.1 | 0.7 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.1 | 12.9 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 0.4 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.4 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.7 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 0.3 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.1 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.1 | 1.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 1.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 1.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.4 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.1 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 1.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.4 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.3 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.1 | 0.4 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.3 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.9 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 1.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.3 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 2.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 1.0 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.9 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.1 | GO:1901859 | regulation of mitochondrial DNA replication(GO:0090296) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.1 | 0.4 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.4 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 1.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 4.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.6 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 1.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 1.5 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.3 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 3.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.6 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.1 | 0.8 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 1.3 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 1.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.4 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.1 | 0.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 2.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.4 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.1 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.1 | 0.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.2 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.1 | 1.7 | GO:0051647 | nucleus localization(GO:0051647) |
0.1 | 0.5 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.6 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 0.1 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.1 | 0.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.1 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.1 | 1.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 1.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.5 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.1 | 0.6 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.7 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 1.4 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.1 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.1 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 1.4 | GO:0042220 | response to cocaine(GO:0042220) |
0.1 | 0.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.3 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 0.8 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.3 | GO:0060433 | bronchus development(GO:0060433) lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.1 | GO:0048597 | post-embryonic eye morphogenesis(GO:0048050) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 0.5 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.1 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.2 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.1 | 0.3 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.1 | 0.2 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.1 | 0.7 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 1.0 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.3 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.1 | 2.4 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 1.9 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.7 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.2 | GO:0031579 | membrane raft organization(GO:0031579) |
0.1 | 0.1 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.1 | 0.5 | GO:0035234 | programmed cell death involved in cell development(GO:0010623) ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 1.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.3 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.9 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.3 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.3 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.1 | 1.9 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.7 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 1.4 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.6 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.1 | 0.7 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
0.1 | 0.4 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.1 | 0.8 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.3 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.1 | 0.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.3 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.2 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.1 | GO:1902402 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 0.5 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 1.1 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 1.1 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 0.1 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.1 | 0.5 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.2 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.1 | 0.2 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 1.2 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.4 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.4 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 2.4 | GO:0001662 | behavioral fear response(GO:0001662) |
0.1 | 1.0 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.5 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.6 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.6 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.4 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.1 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.4 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.3 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.1 | 1.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.4 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.3 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 3.2 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 0.9 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.4 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.9 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.5 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.1 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.1 | 0.2 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.7 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 0.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.3 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.1 | 0.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.1 | 0.3 | GO:0002892 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.1 | 0.7 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.7 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 1.6 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.4 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.3 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 3.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.3 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.4 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.3 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.1 | GO:0002118 | aggressive behavior(GO:0002118) |
0.1 | 0.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 0.9 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.4 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.6 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 0.2 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 4.9 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.1 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.4 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 1.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.1 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.1 | 0.1 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.1 | 0.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.2 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.7 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.5 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.6 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.8 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.6 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.8 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 0.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 1.3 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.1 | 0.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.8 | GO:0071467 | cellular response to pH(GO:0071467) |
0.1 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.2 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.1 | 0.2 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.2 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 0.1 | GO:0051580 | regulation of neurotransmitter uptake(GO:0051580) negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.1 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 0.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.2 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.2 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.1 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.1 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.3 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.1 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.1 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.8 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.6 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.2 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.8 | GO:0048747 | muscle fiber development(GO:0048747) |
0.1 | 0.2 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.9 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.5 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.2 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.5 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.3 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.1 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.2 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.1 | 3.8 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.2 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.1 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.2 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.3 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.1 | 0.5 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.9 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.4 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.3 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.7 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.5 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.6 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.1 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.8 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.4 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 3.2 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.1 | 0.7 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 0.1 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.3 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.1 | 0.7 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 1.3 | GO:0009651 | response to salt stress(GO:0009651) |
0.1 | 0.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.2 | GO:0051340 | regulation of ligase activity(GO:0051340) |
0.1 | 0.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.1 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.1 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.4 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.3 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 0.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.2 | GO:1904478 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.1 | 0.3 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.1 | 1.0 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.1 | 0.1 | GO:0045472 | response to ether(GO:0045472) |
0.1 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 2.8 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.1 | 0.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.3 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 0.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.1 | 0.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.8 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 0.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.1 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) |
0.1 | 0.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.1 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.1 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.1 | 0.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.3 | GO:0007031 | peroxisome organization(GO:0007031) |
0.1 | 0.3 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.5 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.1 | 0.1 | GO:0051231 | spindle elongation(GO:0051231) |
0.1 | 0.8 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.3 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.1 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.1 | 2.1 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.1 | 0.3 | GO:0045078 | regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.1 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 0.1 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 | 0.5 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 0.5 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.1 | 0.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.6 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.5 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.1 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.1 | 0.3 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.6 | GO:0035904 | aorta development(GO:0035904) |
0.1 | 1.8 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.2 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.8 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.1 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) |
0.1 | 0.2 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
0.1 | 0.4 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.5 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.1 | 1.5 | GO:2000181 | negative regulation of blood vessel morphogenesis(GO:2000181) |
0.1 | 0.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.3 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.2 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 | 0.3 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.3 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.2 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.5 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 2.1 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.1 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.1 | 0.1 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.1 | 0.1 | GO:0090083 | inclusion body assembly(GO:0070841) regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.1 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.1 | 0.5 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.1 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.1 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.1 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.1 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.1 | 0.5 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 1.2 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 0.2 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.8 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.5 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 3.2 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 0.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.1 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.1 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.4 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.5 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.0 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.0 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.0 | 0.4 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.0 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.0 | 0.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.0 | 0.3 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 2.5 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.0 | 0.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.0 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.0 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.1 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.0 | 1.5 | GO:0048017 | inositol lipid-mediated signaling(GO:0048017) |
0.0 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 0.0 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.0 | 0.5 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.0 | 1.1 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.0 | 0.2 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.3 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.0 | 0.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.0 | GO:1903825 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
0.0 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.0 | 0.1 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.3 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.5 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.0 | 0.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.0 | 0.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.0 | 0.0 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.0 | 0.0 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.0 | 0.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.0 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.0 | 0.3 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.5 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.3 | GO:0050931 | pigment cell differentiation(GO:0050931) |
0.0 | 0.0 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.7 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.0 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 1.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.1 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.0 | 0.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.1 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.0 | 0.0 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.0 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 1.7 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.0 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.6 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.1 | GO:0006885 | regulation of pH(GO:0006885) |
0.0 | 0.7 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.1 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.0 | 1.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.0 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.0 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 0.0 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 0.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.2 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.6 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.6 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.0 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.0 | 0.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.2 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.3 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.0 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.1 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.1 | GO:1990089 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.0 | 0.0 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.0 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.0 | 0.2 | GO:0021543 | pallium development(GO:0021543) |
0.0 | 0.4 | GO:0042269 | regulation of natural killer cell mediated immunity(GO:0002715) regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.0 | 0.0 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.0 | 0.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 1.6 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.0 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.7 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.3 | GO:0002762 | negative regulation of myeloid leukocyte differentiation(GO:0002762) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.2 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.6 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.0 | 0.8 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 0.0 | GO:0060426 | lung vasculature development(GO:0060426) |
0.0 | 0.6 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.1 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.0 | 0.3 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 0.8 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.1 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
0.0 | 0.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.1 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.0 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.0 | 0.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.0 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.0 | 0.0 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.0 | 0.0 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.4 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.1 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.0 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.2 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.0 | 0.0 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.0 | 0.4 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.8 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.0 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.0 | 0.2 | GO:0001947 | heart looping(GO:0001947) |
0.0 | 0.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.0 | 1.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.0 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.1 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.0 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.0 | 0.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.0 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.0 | 0.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.0 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.0 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.0 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 1.3 | GO:0015698 | inorganic anion transport(GO:0015698) |
0.0 | 0.0 | GO:0007614 | short-term memory(GO:0007614) |
0.0 | 0.0 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.0 | 0.0 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.4 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 0.0 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.2 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.0 | GO:0022605 | oogenesis stage(GO:0022605) negative regulation of female gonad development(GO:2000195) |
0.0 | 0.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.0 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.0 | 0.1 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.0 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.0 | GO:0045979 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.1 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.0 | 0.0 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.0 | 0.3 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.5 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 0.1 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
0.0 | 0.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.0 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.0 | 0.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.0 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.0 | GO:0003143 | embryonic heart tube morphogenesis(GO:0003143) |
0.0 | 0.2 | GO:0046849 | bone remodeling(GO:0046849) |
0.0 | 0.1 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.0 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.0 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 1.4 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.1 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.0 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.0 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.0 | GO:0051645 | Golgi localization(GO:0051645) |
0.0 | 0.0 | GO:0071312 | cellular response to alkaloid(GO:0071312) |
0.0 | 0.2 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.4 | GO:0031497 | chromatin assembly(GO:0031497) |
0.0 | 0.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.0 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.0 | 0.1 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.2 | GO:0005977 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.0 | 0.0 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.1 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.2 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.2 | GO:0031929 | TOR signaling(GO:0031929) |
0.0 | 0.0 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.0 | 0.0 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.0 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.0 | 0.0 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.0 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.0 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.0 | 0.1 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 0.0 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.0 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.9 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.2 | 4.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.1 | 4.5 | GO:0072487 | MSL complex(GO:0072487) |
0.8 | 2.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.7 | 2.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.7 | 4.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.7 | 2.1 | GO:0000811 | GINS complex(GO:0000811) |
0.7 | 2.0 | GO:0031523 | Myb complex(GO:0031523) |
0.6 | 0.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.6 | 1.9 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.6 | 1.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.6 | 4.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.6 | 1.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.6 | 2.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.6 | 1.7 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.6 | 1.7 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.5 | 1.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.5 | 1.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 1.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.5 | 1.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.5 | 0.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.5 | 1.5 | GO:0036396 | MIS complex(GO:0036396) |
0.5 | 1.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.5 | 2.4 | GO:0045180 | basal cortex(GO:0045180) |
0.5 | 3.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.5 | 2.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.5 | 0.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 1.4 | GO:0031417 | NatC complex(GO:0031417) |
0.5 | 2.3 | GO:0008091 | spectrin(GO:0008091) |
0.5 | 1.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.5 | 0.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.4 | 1.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 2.1 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 3.4 | GO:0001939 | female pronucleus(GO:0001939) |
0.4 | 0.8 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.4 | 6.3 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.4 | 1.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.4 | 1.2 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 2.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 0.8 | GO:0043219 | lateral loop(GO:0043219) |
0.4 | 0.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 1.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 3.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.4 | 1.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.4 | 1.1 | GO:0055087 | Ski complex(GO:0055087) |
0.4 | 0.4 | GO:0030891 | VCB complex(GO:0030891) |
0.4 | 1.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 1.1 | GO:0043293 | apoptosome(GO:0043293) |
0.4 | 3.7 | GO:0016580 | Sin3 complex(GO:0016580) |
0.4 | 5.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.4 | 1.1 | GO:0071942 | XPC complex(GO:0071942) |
0.4 | 1.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 3.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 6.8 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 1.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 1.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 1.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 1.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 3.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 2.5 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 2.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 1.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 1.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 0.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 1.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 0.9 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 10.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 0.9 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.3 | 0.9 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.3 | 2.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 1.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 0.8 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.3 | 1.1 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 1.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.3 | 0.8 | GO:1990462 | omegasome(GO:1990462) |
0.3 | 1.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 0.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 0.3 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.3 | 2.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 0.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 0.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 0.8 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 0.8 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.3 | 0.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.3 | 3.9 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.3 | 0.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 3.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 1.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 2.0 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.3 | 0.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 1.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.3 | 0.5 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 2.5 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 0.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 0.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.7 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 0.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 1.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 4.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 1.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 1.2 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 1.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 1.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 1.4 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 0.9 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 3.2 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 3.3 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 2.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 0.7 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 4.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 1.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 0.6 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 0.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 0.6 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.2 | 1.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 2.3 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 0.8 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 1.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 1.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 1.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 2.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 3.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 1.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 1.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 6.0 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 1.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 2.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 0.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.6 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.6 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 1.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 5.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 0.6 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 1.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 1.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 0.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 0.4 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 1.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 1.8 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 1.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 7.2 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.2 | 3.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 1.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 1.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 0.2 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 2.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 0.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 3.2 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 1.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.5 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 0.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 1.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 1.7 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 0.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 7.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 3.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 2.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 1.9 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 4.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 0.7 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 2.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 1.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 10.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 0.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.2 | 1.5 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 0.5 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 4.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 1.9 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 0.3 | GO:0044393 | microspike(GO:0044393) |
0.2 | 3.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.9 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 0.9 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.3 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 0.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 0.3 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 0.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 1.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 0.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 11.7 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 1.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.4 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 8.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 1.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 3.4 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 2.4 | GO:0005901 | caveola(GO:0005901) |
0.1 | 8.2 | GO:0016605 | PML body(GO:0016605) |
0.1 | 5.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 1.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 1.2 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.1 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 5.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 1.6 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.4 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 6.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 1.4 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 4.0 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 1.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 1.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 12.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 6.8 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 1.7 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.6 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 0.5 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.5 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 0.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 1.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 1.4 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 11.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 2.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 2.2 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.6 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 1.0 | GO:0001741 | XY body(GO:0001741) |
0.1 | 2.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 1.0 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 3.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 10.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 2.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 3.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 1.4 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 1.5 | GO:0031256 | leading edge membrane(GO:0031256) |
0.1 | 0.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 0.6 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 2.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 1.8 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 2.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 1.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 2.6 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.1 | GO:0097451 | astrocyte end-foot(GO:0097450) glial limiting end-foot(GO:0097451) |
0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 1.1 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 3.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 3.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 1.1 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 3.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 1.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.3 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 7.9 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 0.2 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 20.3 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.1 | 1.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 1.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 1.6 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 3.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.4 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 1.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 7.3 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 5.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 7.8 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 0.1 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.6 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 1.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 1.9 | GO:0005844 | polysome(GO:0005844) |
0.1 | 13.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 1.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.1 | GO:0002141 | stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 2.6 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 1.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.8 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 1.1 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 3.1 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 1.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 5.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 1.7 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 2.9 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 7.6 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 1.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 1.9 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.1 | 0.4 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 3.1 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 82.1 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 5.0 | GO:0030133 | transport vesicle(GO:0030133) |
0.1 | 2.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.4 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.6 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.1 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 5.7 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 1.1 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 2.4 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 1.8 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 58.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 5.1 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 0.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.4 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
0.1 | 0.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 1.8 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.1 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 1.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.2 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.0 | 32.2 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 3.3 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.8 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.4 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 3.1 | GO:0098552 | side of membrane(GO:0098552) |
0.0 | 11.9 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.4 | GO:0072372 | primary cilium(GO:0072372) |
0.0 | 0.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 28.3 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.0 | 0.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 24.5 | GO:0043230 | extracellular organelle(GO:0043230) |
0.0 | 6.7 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 1.6 | GO:0044297 | cell body(GO:0044297) |
0.0 | 0.4 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.9 | GO:0097458 | neuron part(GO:0097458) |
0.0 | 0.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 1.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.0 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 1.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.0 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 79.0 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 3.9 | GO:0031982 | vesicle(GO:0031982) |
0.0 | 0.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.0 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 2.4 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 0.0 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 1.9 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 23.2 | GO:0005622 | intracellular(GO:0005622) |
0.0 | 0.0 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 11.8 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.0 | GO:0005581 | collagen trimer(GO:0005581) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.1 | 3.3 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.9 | 4.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.9 | 2.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.8 | 2.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.8 | 3.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.8 | 2.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.8 | 2.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.8 | 2.3 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.7 | 4.4 | GO:0043426 | MRF binding(GO:0043426) |
0.7 | 2.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.7 | 2.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.7 | 2.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.7 | 2.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.7 | 2.6 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.6 | 1.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.6 | 2.5 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.6 | 7.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.6 | 2.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.6 | 1.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.6 | 0.6 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.6 | 2.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.6 | 1.2 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.6 | 1.7 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.6 | 2.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.6 | 2.8 | GO:0070061 | fructose binding(GO:0070061) |
0.6 | 0.6 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.6 | 1.7 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 1.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 1.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.5 | 0.5 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.5 | 6.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.5 | 2.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.5 | 1.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.5 | 2.6 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.5 | 1.6 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.5 | 1.6 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.5 | 1.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.5 | 1.5 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.5 | 3.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.5 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.5 | 2.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.5 | 5.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.5 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.5 | 1.5 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 2.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.5 | 1.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 1.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.5 | 1.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.5 | 3.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.5 | 1.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.5 | 1.9 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.5 | 1.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 2.8 | GO:0043814 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.5 | 0.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.5 | 1.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.5 | 1.4 | GO:0004386 | helicase activity(GO:0004386) |
0.5 | 0.9 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.5 | 0.5 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.5 | 5.9 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.5 | 2.7 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.5 | 1.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.4 | 4.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.4 | 1.3 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.4 | 2.7 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.4 | 1.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.4 | 1.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 1.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 1.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 2.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 3.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.4 | 5.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 1.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 1.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 3.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.4 | 0.9 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.4 | 5.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 0.8 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.4 | 1.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 0.4 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.4 | 1.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 1.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 2.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 1.6 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.4 | 1.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 1.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 1.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 1.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.4 | 2.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 1.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 1.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 0.4 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.4 | 1.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 1.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 3.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 1.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.4 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 0.8 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.4 | 1.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.4 | 1.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 1.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.4 | 1.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 2.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 2.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 1.8 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 3.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 1.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 0.7 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 1.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 3.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.4 | 5.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.4 | 1.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.4 | 1.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.4 | 1.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.4 | 3.5 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.4 | 2.8 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.4 | 1.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.4 | 1.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.4 | 1.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 1.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.4 | 6.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 1.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.3 | 0.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 1.7 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 2.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 1.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.3 | 1.7 | GO:0018471 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.3 | 1.7 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 0.7 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.3 | 1.7 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 3.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 3.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.3 | 2.7 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.3 | 1.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 2.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 4.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 0.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 1.0 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.3 | 1.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 0.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.3 | 1.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 1.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.3 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 1.9 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 1.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 1.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 0.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.3 | 0.6 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.3 | 3.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 1.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 0.9 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 0.9 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 0.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.3 | 9.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.3 | 1.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.3 | 2.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 1.2 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.3 | 1.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 1.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 5.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 0.3 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.3 | 3.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.3 | 2.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 0.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 0.9 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 1.1 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 0.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.3 | 3.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.3 | 0.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 2.0 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 1.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 2.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 2.6 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.3 | 0.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.3 | 1.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 1.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 1.4 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.3 | 3.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 1.1 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.3 | 2.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 1.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.3 | 2.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 1.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 1.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 2.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 0.5 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 1.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 2.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 0.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 5.7 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.3 | 3.3 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 1.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 0.8 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 0.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 1.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 2.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 3.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 1.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 0.2 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 1.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 1.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 2.9 | GO:0031404 | chloride ion binding(GO:0031404) |
0.2 | 1.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 2.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 0.7 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 0.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 1.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 0.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 2.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 0.7 | GO:0090079 | translation repressor activity, nucleic acid binding(GO:0000900) translation regulator activity, nucleic acid binding(GO:0090079) |
0.2 | 0.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 2.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 0.7 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 1.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 0.9 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 0.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 1.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.7 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 1.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 1.2 | GO:0000988 | transcription factor activity, protein binding(GO:0000988) |
0.2 | 0.7 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 0.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 0.7 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 0.7 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.2 | 1.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 0.5 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.2 | 1.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 3.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 1.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 1.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.5 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.2 | 2.0 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 8.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.9 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 0.7 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 1.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 0.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.4 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 1.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 1.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 1.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 1.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 0.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 5.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 0.4 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.2 | 0.6 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 5.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 0.8 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 0.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 1.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.2 | 2.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 4.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 3.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 0.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 0.6 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 0.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 0.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 1.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 1.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 0.6 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 3.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 0.4 | GO:0070905 | serine binding(GO:0070905) |
0.2 | 0.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 3.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 0.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 1.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 1.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 0.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 1.2 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 5.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 1.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.6 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.2 | 1.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 1.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.8 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 17.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.2 | 0.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 2.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 1.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 1.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 1.7 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 1.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 0.8 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 0.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 1.7 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 0.7 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 2.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 0.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.2 | 0.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 1.3 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 1.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.7 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.2 | 1.3 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 0.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 0.7 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.2 | 1.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.7 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.2 | 1.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 0.5 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 1.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 3.7 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.9 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 0.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 0.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 0.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.2 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.2 | 0.9 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 9.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 1.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 0.7 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 7.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 2.4 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.2 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 4.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 1.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 2.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 2.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 1.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 1.0 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 4.1 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
0.2 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 0.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 0.7 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 0.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 0.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.5 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 2.0 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 0.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 0.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 16.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 0.2 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.2 | 0.5 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 1.3 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.2 | 2.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 1.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 0.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 1.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 1.3 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 4.1 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.2 | 1.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 3.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 0.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 5.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 1.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 1.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 2.3 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.2 | 2.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.5 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.2 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 0.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 0.8 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.2 | 1.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 1.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 0.5 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.2 | 4.5 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.4 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 1.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 1.5 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 1.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.9 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 1.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 2.9 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 1.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 1.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 1.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 1.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 1.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 1.0 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 2.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 2.1 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.1 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.4 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.1 | 0.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 1.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.1 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.1 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 4.9 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 1.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 1.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.7 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.1 | 0.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 2.9 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.1 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 2.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.4 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.3 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 1.0 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 1.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 4.0 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 3.6 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 1.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 2.5 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 14.6 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 1.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 2.1 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.1 | GO:0070697 | activin receptor binding(GO:0070697) |
0.1 | 0.2 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 1.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 1.0 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 12.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.2 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 1.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 1.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 1.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.4 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 1.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.8 | GO:0052790 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.1 | 0.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 2.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 1.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 1.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.2 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 1.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 1.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 1.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 0.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.5 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 4.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.8 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.6 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.5 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 2.0 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.3 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.4 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.1 | 3.8 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.8 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.1 | 1.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.6 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 2.8 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 2.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.6 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 5.3 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 1.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 1.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 2.0 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 2.1 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 4.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 2.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 6.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.2 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 1.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 3.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 2.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 2.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 2.7 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 1.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.9 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 2.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.2 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 0.3 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.1 | 0.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.3 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.1 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 1.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 3.8 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.5 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.9 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.7 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 7.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 1.9 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.4 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 2.5 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.9 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.5 | GO:0018498 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 1.1 | GO:0004601 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 0.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 1.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 1.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.3 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 1.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 11.2 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 0.9 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 1.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.1 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.1 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.4 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 1.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.9 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.1 | 0.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 1.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.2 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.2 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.1 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 1.9 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.4 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 2.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.3 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 1.9 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 1.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.3 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.1 | 1.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 1.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 1.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 1.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.7 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.9 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.1 | 0.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 0.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 1.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 1.8 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.4 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 1.7 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.3 | GO:0016454 | C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.2 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.1 | 9.0 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 2.6 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.5 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 0.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 6.7 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.1 | 1.3 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 7.6 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 1.1 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
0.1 | 1.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 1.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.7 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 3.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.4 | GO:0042562 | hormone binding(GO:0042562) |
0.1 | 0.2 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.4 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 3.6 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.0 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 2.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.0 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 1.0 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.2 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.0 | 1.0 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.0 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.0 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.4 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.0 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.7 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 1.6 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.7 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.0 | 0.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 1.9 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.0 | 0.3 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 1.6 | GO:0051020 | GTPase binding(GO:0051020) |
0.0 | 0.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 10.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0009975 | cyclase activity(GO:0009975) |
0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 2.0 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.2 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.3 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.3 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.0 | 0.1 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.0 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 4.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 22.2 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.2 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 1.2 | GO:0015085 | calcium ion transmembrane transporter activity(GO:0015085) |
0.0 | 0.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.2 | GO:0034817 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.0 | 0.0 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.1 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.8 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.7 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.5 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.6 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.3 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 2.9 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 2.3 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.0 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.3 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.0 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 1.3 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.0 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 1.2 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 4.1 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.7 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.4 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 1.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.7 | 1.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.6 | 0.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 0.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.5 | 10.5 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.5 | 0.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.4 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 10.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.4 | 12.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.4 | 2.2 | ST STAT3 PATHWAY | STAT3 Pathway |
0.4 | 5.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.4 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 3.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 2.3 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 4.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 13.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 5.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 9.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 0.8 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.3 | 11.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 2.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.3 | 1.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 1.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 6.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 9.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 3.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 4.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 2.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 1.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 7.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 3.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 1.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 11.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 12.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 5.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 7.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 1.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 2.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 9.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 1.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 1.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 4.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 5.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 6.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 16.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 1.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 0.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 3.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 4.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 0.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 2.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 1.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 3.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 4.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 0.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 4.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 2.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 1.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 2.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 1.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 5.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 4.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.9 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 2.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 5.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 3.1 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 2.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.8 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 2.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 2.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 3.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 3.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 3.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 3.0 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 2.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 1.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 2.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 11.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 1.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 5.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.6 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.7 | 1.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.6 | 1.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.5 | 3.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 7.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.5 | 0.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.5 | 2.5 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.5 | 10.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.5 | 4.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.5 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.5 | 0.9 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.5 | 4.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 8.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.4 | 3.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 3.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.4 | 4.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.4 | 8.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.4 | 3.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 1.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.4 | 2.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 4.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 5.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 0.7 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
0.3 | 3.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 6.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 1.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 0.7 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.3 | 5.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 2.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 2.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 6.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 8.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 5.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 4.2 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.3 | 4.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.3 | 1.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 3.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 7.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 1.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 2.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 4.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 3.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 2.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 3.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 3.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 1.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 5.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 2.4 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.3 | 2.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 3.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 0.3 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.3 | 20.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 3.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 1.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 2.6 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.2 | 3.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 7.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 2.5 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.2 | 3.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 2.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 5.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 2.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 4.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 1.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 3.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 0.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 0.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 3.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 0.8 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 1.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 1.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 1.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 3.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 0.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 2.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 0.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 0.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 0.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 12.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 3.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 3.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 1.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 0.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 2.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 4.1 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.2 | 1.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 0.4 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.2 | 2.0 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 11.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 0.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 1.8 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 0.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 0.5 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.2 | 1.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 10.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 0.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 2.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 3.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 1.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 4.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 2.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 2.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 6.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 3.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 1.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 5.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 1.8 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 2.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.5 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 2.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 1.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 4.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.3 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 2.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 2.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 1.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 5.4 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 2.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.3 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 0.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 2.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.1 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 1.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 12.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 2.4 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.6 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.8 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 2.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 2.3 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 2.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.1 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 6.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.5 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 2.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.1 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.1 | 1.0 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 1.0 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.0 | 1.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.2 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.0 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.5 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 1.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 2.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 1.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 1.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.0 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.0 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.9 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 1.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.0 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.0 | 1.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |